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ABSTRACT 
 
 
Chong, Voon Joe. M.S.B.M.E., Purdue University, May 2012. Preparation and Evaluation 
of Novel Antibacterial Dental Resin Composites. Major Professor: Dr. Dong Xie. 
 
 
Both quaternary ammonium bromide (QAB) and furanone derivatives were 
synthesized, characterized and formulated into dental resin composites for improved 
antibacterial properties. Compressive strength (CS) and S. mutans viability were used to 
evaluate the mechanical strength and antibacterial activity of the restoratives. The effects 
of chain length, loading, saliva and aging on CS and S. mutans viability were investigated. 
 
Chapter 2 describes how we studied and evaluated the formulated antibacterial 
resin composites by incorporating the synthesized QAB-containing oligomers into the 
formulation. The results show that all the QAB-modified resin composites showed 
significant antibacterial activity and mechanical strength reduction. Increasing chain 
length and loading significantly enhanced the antibacterial activity but dramatically 
reduced the CS as well. The 30-day aging study showed that the incorporation of the 
QAB accelerated the degradation of the composite, suggesting that the QAB may not be 
well suitable for development of antibacterial dental resin composites or at least the QAB 
loading should be well controlled. 
 
Chapter 3 describes how we studied and evaluated the formulated antibacterial 
resin composite by incorporating the synthesized furanone derivative into the  
formulation. The results show that the modified resin composites showed a significant 
antibacterial activity without substantially decreasing the mechanical strengths. With 5 to 
30% addition of the furanone derivative, the composite kept its original CS unchanged 
 viii 
 
viii 
but showed a significant antibacterial activity with a 16-68% reduction in the S. mutans 
viability. Further, the antibacterial function of the new composite was found not to be 
affected by human saliva. The aging study indicates that the composite may have a long-
lasting antibacterial function. 
 
In summary, we have developed a novel QAB- and furanone-containing 
antibacterial system for dental restoratives. Both QAB- and furanone-modified resin 
composites have demonstrated significant antibacterial activities. The QAS-modified 
experimental resin composite may not be well suitable for development of antibacterial 
dental resin composites due to its accelerated degradation in water unless the QAB 
loading is well controlled. The furanone-modified resin composite shows nearly no 
reduction in mechanical strength after incorporation of the antibacterial furanone 
derivative. It appears that the furanone-modified resin composite is a clinically attractive 
dental restorative that can be potentially used for long-lasting restorations due to its high 
mechanical strength and permanent antibacterial function. 
                          
 
1 
 
 
 
 
 
1. INTRODUCTION 
 
 
1.1 Background 
Long-lasting restoratives and restoration are clinically attractive because they can 
reduce patients’ pain and expense as well as the number of their visits to dental offices. In 
dentistry, both restorative materials and oral bacteria are believed to be responsible for 
the restoration failure. Secondary caries is found to be the main reason to the restoration 
failure of dental restoratives including resin composites and glass-ionomer cements. 
Secondary caries that often occurs at the interface between the restoration and the cavity 
preparation is primarily caused by demineralization of tooth structure due to invasion of 
plaque bacteria (acid-producing bacteria) such as Streptococcus mutans (S. mutans) in the 
presence of fermentable carbohydrates. To make long-lasting restorations, the materials 
should be made antibacterial. Although numerous efforts have been made on improving 
antibacterial activities of dental restoratives, most of them have been focused on release 
or slow-release of various incorporated low molecular weight antibacterial agents such as 
antibiotics, zinc ions, silver ions, iodine and chlorhexidine. Yet release or slow-release 
can lead or has led to a reduction of mechanical properties of the restoratives over time, 
short-term effectiveness, and possible toxicity to surrounding tissues if the dose or release 
is not properly controlled. Materials containing quaternary ammonium salt (QAS) groups 
have been studied extensively as an important antimicrobial material and used for a 
variety of applications due to their potent antimicrobial activities. These materials are 
found to be capable of killing bacteria that are resistant to other types of cationic 
antibacterials. The examples of the QAS-containing materials as antibacterials for dental 
restoratives include incorporation of a methacryloyloxydodecyl pyridinium bromide as an 
antibacterial monomer into resin composites, use of methacryloxylethyl cetyl ammonium 
chloride as a component for antibacterial bonding agents, and incorporation of quaternary 
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ammonium polyethylenimine nanoparticles into resin composites. All these studies found 
that the QAS-containing materials did exhibit significant antibacterial activities. Recently 
furanone derivatives have been found to have strong antitumor and antibacterial functions. 
In this thesis, we would like to study the antibacterial effect of both QAB and furanone 
derivatives on dental resin composites. 
 
 
1.2. Hypothesis and Objectives 
It is our hypothesis that incorporating newly synthesized QAB and/or furanone 
derivative into experimental dental resin composite would provide a novel route for 
formulation of novel antibacterial dental restoratives.   
 
The objectives of the study in this thesis were: (1) to synthesize and characterize 
QAB-containing oligomers and/or furanone derivative; (2) to formulate the resin 
composites with either QAB or furanone derivatives; (3) to evaluate the mechanical 
strengths of the formed restoratives; and (4) to evaluate the antibacterial activity of the 
formulated restoratives. 
 
Chapter 2 mainly describes the synthesis, characterization, formulation and 
evaluation of the QAB oligomer-constructed resin composites. Chapter 3 mainly 
describes the synthesis, characterization, formulation and evaluation of the resin 
composites composed of the furanone derivative. The effects of chain length, loading, 
saliva and aging on CS and S. mutans viability were also investigated. 
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2. SYNTHESIS AND EVALUATION OF A NOVEL ANTIBACTERIAL 
DENTAL RESIN COMPOSITE WITH QUATERNARY AMMONIUM 
SALTS 
 
 
2.1  Abstract 
The novel quaternary ammonium bromide (QAB)-containing oligomers were 
synthesized and applied for developing an antibacterial resin composite. Compressive 
strength (CS) and S. mutans (an oral bacteria strain) viability were used to evaluate the 
mechanical strength and antibacterial activity of the formed composites. All the QAB-
modified resin composites showed significant antibacterial activity and mechanical 
strength reduction. Increasing chain length and loading significantly enhanced the 
antibacterial activity but dramatically reduced the CS as well. The 30-day aging study 
showed that the incorporation of the QAB accelerated the degradation of the composite, 
suggesting that the QAB may not be well suitable for development of antibacterial dental 
resin composites or at least the QAB loading should be well controlled, unlike its use in 
dental glass-ionomer cements. The work in this study is beneficial and valuable to those 
who are interested in studying antibacterial dental resin composites. 
 
 
2.2  Introduction 
Long-lasting restoratives and restoration are clinically attractive because they can 
reduce patents’ pain and expense as well as the number of their visits to dental offices [1-
4]. In dentistry, both restorative materials and oral bacteria are believed to be responsible 
for the restoration failure [2]. Secondary caries is found to be the main reason to the 
restoration failure of dental restoratives including resin composites and glass-ionomer 
cements [1-4]. Secondary caries that often occurs at the interface between the restoration 
and the cavity preparation is primarily caused by demineralization of tooth structure due 
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to invasion of plaque bacteria (acid-producing bacteria) such as Streptococcus mutans (S. 
mutans) in the presence of fermentable carbohydrates [4]. To make long-lasting 
restorations, the materials should be made antibacterial. Although numerous efforts have 
been made on improving antibacterial activities of dental restoratives, most of them have 
been focused on release or slow-release of various incorporated low molecular weight 
(MW) antibacterial agents such as antibiotics, zinc ions, silver ions, iodine and 
chlorhexidine (CHX) [5-9]. Yet release or slow-release can lead or has led to a reduction 
of mechanical properties of the restoratives over time, short-term effectiveness, and 
possible toxicity to surrounding tissues if the dose or release is not properly controlled [5-
9]. 
 
Materials containing quaternary ammonium salt (QAS) or phosphonium salt (QPS) 
groups have been studied extensively as an important antimicrobial material and used for 
a variety of applications due to their potent antimicrobial activities [10-14]. These 
materials are found to be capable of killing bacteria that are resistant to other types of 
cationic antibacterials [15]. The examples of QAS-containing materials as antibacterials 
for dental restoratives include incorporation of a methacryloyloxydodecyl pyridinium 
bromide (MDPB) as an antibacterial monomer into resin composites [12], use of 
methacryloxylethyl cetyl ammonium chloride (DMAE-CB) as a component for 
antibacterial bonding agents [16, 17], and incorporation of quaternary ammonium 
polyethylenimine (PEI) nanoparticles into composite resins [18, 19]. All these studies 
found that QAS-containing materials did exhibit significant antibacterial activities. In this 
study, we proposed to synthesize the novel QAS-containing oligomers for developing 
antibacterial dental resin composites. 
 
The objective of this study was to synthesize new quaternary ammonium salt 
(QAS)-containing oligomers, incorporate them to dental resin composites, and evaluate 
the effects of these new oligomers on the mechanical strength and antibacterial activity of 
the formed composites. 
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2.3  Experiments 
 
 
2.3.1  Materials 
Bromoethane, bromohexane, bromododecane, bromohexadecane, 2-
dimethylaminoethanol (DMAE), 2-hydroxyethyl methacrylate (HEMA), 1,2,4,5-
benzenetetracarboxylic dianhydride (BTCDA), 3,3’,4,4’-benzophenonetetracarboxylic 
dianhydride (BPTCDA), 4,4’-(4,4’-isopropylidenediphenoxy)-bis(phthalic anhydride) 
(IPDPBisPA), triethylene glycol dimethacrylate (TEGDMA), bisphenol A glycerolate 
dimethacrylate (BisGMA), dl-camphoroquinone (CQ), 2-(dimethylamino)ethyl 
methacrylate (DMAEMA), pyridine, N,N'-dicyclohexylcarbodiimide (DCC), N-
methylpyrrolidone (NMP) and hexane were used as received from VWR International Inc 
(Bristol, CT) without further purifications. The untreated glass fillers for Herculite XRV 
(0.7 microns) were used as received from Sybron Dental Specialties (Newport Beach, 
CA). 
 
 
2.3.2. Synthesis of The Polymerizable Oligomers Bearing Quaternary  
Ammonium Bromide (QAB) 
The polymerizable oligomer bearing quaternary ammonium bromide (QAB) was 
synthesized via three steps: synthesis of the hydroxyl group-containing QAB, coupling 
the QAB onto the oligomer, and introduction of the methacrylate groups onto the 
oligomer. Briefly, (1) to a flask containing DMAE (0.01 mol) in methanol, 
bromododecane (0.013 mol) was added. The reaction was run at room temperature 
overnight. After most of methanol was removed, the mixture was washed with hexane 3 
times. The formed 2-dimethyl-2-dodecyl-1-hydroxyethylammonium bromide (or namely 
B12) was purified by dissolving in methanol and washing with hexane several times 
before drying in a vacuum oven; (2) to a flask containing BPTCDA (0.01 mol) in NMP, 
B12 (0.013 mol) was added in the presence of pyridine. After the reaction was run at 60 
oC for 4 h, the mixture was precipitated from hexane, followed by washing with hexane 3 
times; (3) the purified product BPDQAB (0.01 mol, an adduct of BPTCDA and B12) in 
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NMP was used to react with HEMA (0.013 mol) in the presence of DCC (0.013 mol) and 
pyridine (1.5% by weight of HEMA). After the reaction was run at room temperature 
overnight, the mixture was precipitated with hexane, followed by washing with hexane 
several times. The purified oligomer BPDQABDMA (an adduct of BPDQAB and HEMA) 
was then dried in a vacuum oven at room temperature prior to use. The other two 
oligomers, BDQABDMA (an adduct of BDQAB and HEMA) and IPDPDQABDMA (an 
adduct of IPDPDQAB and HEMA), were synthesized the same as shown above. The 
structures of three starting dianhydrides, TEGDMA and BisGMA as well as the synthesis 
scheme are shown in Figure 2.1. 
 
 
2.3.3  Characterization 
The chemical structures of the synthesized oligomers were characterized by 
Fourier transform-infrared (FT-IR) spectroscopy and nuclear magnetic resonance (NMR) 
spectroscopy. The proton NMR (1HNMR) spectra were obtained on a 500 MHz Bruker 
NMR spectrometer (Bruker Avance II, Bruker BioSpin Corporation, Billerica, MA) using 
deuterated dimethyl sulfoxide and chloroform as solvents and FT-IR spectra were 
obtained on a FT-IR spectrometer (Mattson Research Series FT/IR 1000, Madison, WI).  
 
 
2.3.4  Sample Preparation for Mechanical and Strength Tests 
The experimental resin composites were formulated with a two-component system 
(liquid and powder) [20]. The liquid was formulated with the newly synthesized oligomer, 
BisGMA, TEGDMA, CQ and DMAEMA. The synthesized oligomer, BisGMA and 
TEGDMA were mixed in a ratio of oligomer/BisGMA/TEGDMA = 30/35/35 (oligomer = 
30%) unless specified. CQ (1.0% by weight) and DMAEMA (2.0%) were added for 
photo-initiation. The untreated glass Herculite XRV (0.7 microns) powders were used as 
fillers and treated with γ-(trimethoxysilyl)propyl methacrylate, following the published 
protocol [21]. A filler level at 75% (by weight) was used throughout the study. 
                          
 
7 
A.
B.
OO
O
O
O
O
C
CH3
CH3
OO
OO
O
O
O
O
C
O OO
O
O
O
O
C
O OO
O
O
O
O
Br
C
O
COOCH2CH2
COOHHOOC
CH2CH2OOC N
CH3
CH3
RN
CH3
CH3
R
Br
Br
C
O
COOCH2CH2
COOOOC
CH2CH2OOC N
CH3
CH3
RN
CH3
CH3
R
CH2CH2OOCC CH2
CH3
CCOOCH2CH2CH2
CH3
Br
HOCH2CH2N(CH3)2
HOCH2CH2N(CH3)2R
Br
+
+
+
RBr
HEMA
where R = (CH2)nCH3 and n = 1, 5, 9 and 13  
C
CH3
CH3
OO CH2CHCH2OOCC
CH3
CH2CCOOCH2CHCH2
CH3
CH2
OHOH
CCOOCH2CH2OCH2CH2OCH2CH2OOCC CH2CH2
CH3CH3
BTCDA BPTCDA
IPDPBisPA
TEGDMA
BisGMA
BPTCDA
BPDQAB
BPDQABDMA
 
Figure 2.1 Structures and and synthesis scheme: A. Structures of BTCDA, BPTCDA, 
IPDPBisPA, TEGDMA and BisGMA; B. Synthesis scheme for preparation of the 
polymerizable quaternized oligomer BPDQABDMA 
 
Specimens were fabricated by thoroughly mixing the liquid with the treated fillers 
at room temperature according to the published protocol [20, 21]. Briefly, the cylindrical 
specimens were prepared in glass tubing with dimensions of 4 mm in diameter by 8 mm 
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in length for compressive strength (CS), 4 mm in diameter by 2 mm in length for 
diametral tensile strength (DTS), and 4 mm in diameter by 2 mm in depth for 
antibacterial tests. The rectangular specimens were prepared in a split Teflon mold with 
dimensions of 3 mm in width by 3 mm in thickness by 25 mm in length for flexural 
strength (FS) test.  All the specimens were exposed to blue light (EXAKT 520 Blue Light 
Polymerization Unit, EXAKT Technologies, Inc., Oklahoma City, OK) for 2 min, 
followed by removing from the mold or conditioned in distilled water at 37 oC for 24 h 
prior to testing, unless specified. 
 
 
2.3.5  Strength Measurements 
CS, DTS and FS tests were performed on a screw-driven mechanical tester (QTest 
QT/10, MTS Systems Corp., Eden Prairie, MN), with a crosshead speed of 1 mm/min. 
The FS test was performed in three-point bending with a span of 20 mm between 
supports. Six to eight specimens were tested to obtain a mean value for each material or 
formulation in each test. CS was calculated using an equation of CS = P/πr2, where P = 
the load at fracture and r = the radius of the cylinder. DTS was determined from the 
relationship DTS = 2P/πdt, where P = the load at fracture, d = the diameter of the cylinder, 
and t = the thickness of the cylinder. FS was obtained using the expression FS = 3Pl/2bd2, 
where P = the load at fracture, l = the distance between the two supports, b = the breadth 
of the specimen, and d = the depth of the specimen. 
 
 
2.3.6  MIC Test for Synthesized QAB 
The minimal inhibitory concentration or MIC of the synthesized QAB was 
determined following the published protocol with a slight modification [22]. Briefly, 
colonies of S. mutans (UA159) were suspended in 5 ml of Tryptic soy Broth (TSB) prior 
to MIC testing. Two-fold serial dilutions of the synthesized QAB were prepared in TSB, 
followed by placing in 96-well flat-bottom microtiter plates with a volume of 250 μl per 
well. The final concentration of the QAB ranged from 1.563 to 2 x 104 µg/ml. The 
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microtiter plate was then inoculated with S. mutans suspension (cell concentration = 5 x 
105 CFU/ml) and incubated at 37 oC for 48 h prior to MIC testing. The absorbance was 
measured at 595 nm via a microplate reader (SpectraMax 190, Molecular Devices, CA) 
to assess the cell growth. Chloehexidine (CHX) and dimethylsulfoxide were used as 
positive and negative controls, respectively. Triple replica was used to obtain a mean 
value for each QAB. 
 
 
2.3.7  Antibacterial Test for the Formed Cements 
The antibacterial test was conducted following the published procedures [23]. S. 
mutans was used for evaluation of antibacterial activity of the studied cements. Briefly, 
colonies of S. mutans (UA159) were suspended in 5 ml of Tryptic soy Broth (TSB), 
supplemented with 1% sucrose, to make a suspension with 108 CFU/ml of S. mutans, 
after 24 h incubation. Specimens pretreated with ethanol (10 sec) were incubated with S. 
mutans in TSB at 37 oC for 48 h under anaerobic condition with 5% CO2. After equal 
volumes of the red and the green dyes (LIVE/DEAD BacLight bacterial viability kit 
L7007, Molecular Probes, Inc., Eugene, OR, USA) were combined in a microfuge tube 
and mixed thoroughly for 1 min, 3 μl of the dye mixture was added to 1 ml of the bacteria 
suspension, mixed by vortexing for 10 sec, sonicating for 10 sec as well as vortexing for 
another 10 sec, and kept in dark for about 15 min, prior to analysis. Then 20 μl of the 
stained bacterial suspension was analyzed using a fluorescent microscope (Nikon 
Microphot-FXA, Melville, NY, USA). Triple replica was used to obtain a mean value for 
each material. 
 
 
2.3.8  Statistical Analysis 
 One-way analysis of variance (ANOVA) with the post hoc Tukey-Kramer 
multiple-range test was used to determine significant differences of mechanical strength 
and antibacterial tests among the materials in each group. A level of α = 0.05 was used for 
statistical significance. 
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2.4  Results and Discussion 
 
 
2.4.1  Characterization 
The characteristic peaks (cm-1) from the FT-IR spectra shown in Figure 2.2 for 
DMAE, bromododecane, B12, BPTCDA and BPDQAB (an adduct of an adduct of 
BPTCDA and B12) are listed in Table 2.1. The appearance of both peaks at 3600-3200 
and 1632 for =N+= groups and disappearance of the peaks at 1040 and 776 for C-N 
groups confirmed the formation of B12. The disappearance of the peaks at 1855 and 1782 
for anhydrides as well as appearance of a broad peak at 3600-2600 for -COOH, a 
relatively sharp peak at 3320 for =N+= and strong peaks at 2924 and 2854 for -CH3 and -
CH2 groups confirmed the formation of BPDQAB. 
 
 
 
 
Figure 2.2 FT-IR spectra for DMAE, bromododecane, B12, BPTCDA and BPDQAB   
(an adduct of BPTCDA and B12): (a) DMAE; (b) bromododecane; (c) B12; (d) 
BPTCDA and (e) BPDQAB 
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The characteristic peaks (cm-1) from the FT-IR spectra shown in Figure 2.3 for 
HEMA, BPDQAB, BPDQABDMA, BDQABDMA and IPDPDQABDMA are listed in 
Table 2. The disappearance of the peak at 3428 (-OH from HEMA) as well as appearance 
of the peaks at 3600-3200 for =N+=, 2923 and 2853 for –CH2- and -CH3 and 1647 for 
C=C groups confirmed the formation of three polymerizable quaternized oligomers. 
 
 
Table 2.1 The characteristic peaks from the FT-IR spectra shown in Figure 2.2 
Material The characteristic peaks (cm-1) 
DMAE 
3399 (O-H stretching), 2944 (C-H stretching on -CH2-), 2861 (C-H stretching on 
-CH3), 2820 and 2779 (C-H stretching on –N(CH3)2), 1459, 1364 and 1268 (C-H 
deformation on –CH2-), 1090 (O-H deformation), and 1040 as well as 776 (C-N 
deformation). 
Bromododecane 2924 (C-H stretching on -CH2-), 2854 (C-H stretching on -CH3), 1465, 1377 and 1255 (C-H deformation on –CH2-), and 722 as well as 647 (C-Br deformation); 
B12 
3600-3200 (=N+= stretching), 2917 (C-H stretching on -CH2-), 2850 (C-H 
stretching on -CH3), 1632 (=N+= deformation),  1470 (C-H deformation on –
CH2-), and 1090 as well as 730 (O-H deformation); 
BPTCDA 
2910 (=C-H stretching on phenyl groups), 1855 and 1782 (two –C=O stretching 
on five-membered ring acid anhydride), 1717 (-C=O stretching on ketone), 1610 
and 1570 (-C=C- stretching on phenyl groups), 1495 (-C=O deformation 
vibration),  1231 (other vibrations on five-membered ring acid anhydrides), and 
1388, 1135, 1069, 917, 715 and 625 (-C=C-and -=C-H stretching, out-of-plane 
and other vibrations on phenyl groups) 
BPDQAB 
3320 (=N+= stretching), 3600-2600 (O-H stretching on –COOH), 2924 (C-H 
stretching on -CH2-), 2854 (C-H stretching on -CH3), 1726 and 1669 (-C=O 
stretching on esters), 1587 (-C=O stretching on ketone), 1467 (-C=O 
deformation vibration), and 1388, 1135, 1069, 917, 715 and 625 (-C=C-and -=C-
H stretching, out-of-plane and other vibrations on phenyl groups) 
 
The characteristic chemical shifts (ppm) from the 1HNMR spectra shown in 
Figure 2.4 for DMEA, bromododecane, B12, BPTCDA and BPDQABDMA are listed in 
Table 2.3. The appearance of all the new peaks in the spectrum, especially at 5.82 and 
6.25 for carbon-carbon double bond and 7.82-8.40 for phenyl groups confirmed the 
successful attachment of HEMA and B12 onto the BPTCDA. 
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Figure 2.3 FT-IR spectra for HEMA, BPDQAB, BPDQABDMA (an adduct of BPDQAB 
and HEMA), BDQABDMA (an adduct of BDQAB and HEMA) and IPDPDQABDMA 
(an adduct of IPDPDQAB and HEMA): (a) HEMA;  (b) BPDQAB; (c) BPDQABDMA; 
(d) BDQABDMA and (e) IPDPDQABDMA 
 
Table 2.2 The characteristic peaks from the FT-IR 
Material The characteristic peaks (cm-1) 
HEMA 
3428 (O-H stretching), 2957 (C-H stretching on -CH2-), 2889 (C-H 
stretching on -CH3), 1719 (-C=O stretching on ester), and 1637 (-
C=C stretching) 
BPDQAB 
3320 (=N+= stretching), 3600-2600 (O-H stretching on –COOH), 2924 (C-H 
stretching on -CH2-), 2854 (C-H stretching on -CH3), 1726 and 1669 (-C=O 
stretching on esters), 1587 (-C=O stretching on ketone), 1467 (-C=O 
deformation vibration), and 1388, 1135, 1069, 917, 715 and 625 (-C=C-and -
=C-H stretching, out-of-plane and other vibrations on phenyl groups) 
BPDQABDMA 
3328 (=N+= stretching), 2924 (C-H stretching on -CH2-), 2854 (C-H stretching 
on -CH3), 1726 (-C=O stretching on esters), 1647 (C=C stretching on 
methacrylates), 1587 (-C=O stretching on ketone), 1467 (-C=O deformation 
vibration), and 1388, 1135, 1069, 917, 715 and 625 (-C=C-and -=C-H 
stretching, out-of-plane and other vibrations on phenyl groups); 
BDQABDMA Similar to BPDQABDMA 
IPDPDQABDMA Similar to both BPDQABDMA and BDQABDMA. 
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Figure 2.4 1H NMR spectra for DMAE, bromododecane, B12, BPTCDA and 
BPDQABDMA: (a) DMAE; (b) bromododecane; (c) B12; (d) BPTCDA and (e) 
BPDQABDMA 
 
 
Table 2.3 The characteristic chemical shifts from HNMR spectra shown in Figure 2.4 
Material The characteristic chemical shifts (ppm) 
DMEA 4.40 (-OH), 3.42 (-CH2OH), 2.30 (-CH2N-) and 2.10 (H3CN-) 
Bromododecane 3.51 (-CH2Br), 1.80 (-CH2CH2Br), 1.38 (-CH2-, all) and 0.89 (-CH3) 
B12 5.25 (-OH), 3.82 (-CH2OH), 3.40 (-CH2N(CH3)2), 3.08 (H3CN-), 1.55 (-CH2CH2N(CH3)2), 1.25 (-CH2- all) and 0.89 (-CH3); 
BPTCDA 7.85-8.40 (-H, all from the phenyl groups) and 2.50 (TMS) 
BPDQABDMA 7.85-8.40 (-H, all from the phenyl groups), 5.82 and 6.25 (=C-, from methacrylates) and all the other chemical shifts similar to those shown on B12 
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2.4.2  Evaluations 
Table 2.4 shows the code, description and MIC of the synthesized QAB. The MIC 
values ranged from 1.563 to 2 x 104µg/ml for B16 to B2. 
 
Figure 2.5 shows the effect of the substitute chain length on the synthesized 
oligomers on CS and S. mutans viability of the experimental resin composite. The mean 
CS value (MPa) was in the decreasing order of B2 > B6 > B12 > B16, where there were 
no statistically significant differences between B2 and B6, between B6 and B12, and 
between B12 and B16 (p > 0.05). Increasing the substitute chain length on the oligomer 
decreased the CS values of the resin composite. The mean S. mutans viability was in the 
decreasing order of B2 > B6 > B12 > B16, where all the resin composites were 
significantly different from each other (p < 0.05). 
 
Figure 2.6 shows the effect of different oligomers on CS and S. mutans viability 
of the resin composite. The mean CS value (MPa) of the dry resin composite was in the 
decreasing order of A > B > C > D, where there were no statistically significant 
differences among B, C and D (p > 0.05). The mean CS value (MPa) of the wet resin 
composite (the composite after conditioning in distilled water for 24 h) was in the 
decreasing order of A > D > C > B, where there were no statistically significant 
differences among B, C and D (p > 0.05). The mean S. mutans viability was in the 
decreasing order of A > D > C > B, where there were no statistically significant 
differences between B and C and between C and D (p > 0.05). 
 
Figure 2.7 shows the effect of the oligomer loading on CS and S. mutans viability. 
Both mean CS value (MPa) and S. mutans viability were in the decreasing order of 10% 
> 20% > 30% > 50% > 70%, where all the resin composites were significantly different 
from each other in either category (p < 0.05). 
 
 
 
                          
 
15 
 
Table 2.4 Codes, description, MIC values of the synthesized QAB 
Code QAB
1 Chain 
length 
MIC 
(μg/ml)2 
B2 2-Dimethyl-2-ethyl-1-hydroxyethylammonium bromide 2 20,000 
B6 2-Dimethyl-2-hexyl-1-hydroxyethylammonium bromide 6 1,000 
B12 2-Dimethyl-2-dodecyl-1-hydroxyethylammonium bromide 12 25 
B16 2-Dimethyl-2-hexadecyl-1-hydroxyethylammonium bromide 16 1.563 
 
1All the QAS were freshly synthesized and water-soluble; 2MIC values were measured as described in the 
text.  
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Figure 2.5 Effect of the substitute chain length on the synthesized QAB on CS and S. 
mutans viability of the resin compiosite: B2, B6, B12 and B16 represent the substitute 
chain length on the synthesized QAB (see codes and description in Table 1). The 
composite was composed of BPDQABDMA/BisGMA/TEGDMA at a ratio of 20:40:40 
(by weight or BPDQABDMA = 20%). Specimens were tested directly for CS and 
incubated with S. mutans for 48 h for antibacterial testing 
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Figure 2.6 Comparison among the resin composites having different QAB-containing 
oligomers via CS and S. mutans viability testing: A, B, C and D stand for the resin 
composites composed of BisGMA/TEGDMA = 50/50 (by weight), 
BDQABDMA/BisGMA/TEGDMA = 30/35/35, BPDQABDMA/BisGMA/TEGDMA = 
30/35/35 and IPDPDQABDMA/BisGMA/TEGDMA = 30/35/35, respectively. CS1 and 
CS2 represent the CS for day and wet resin composites. QAB = B12. Specimens were 
tested directly for CS and incubated with S. mutans for 48 h for antibacterial testing. 
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Figure 2.7 Effect of the QAB loading on CS and S. mutans viability: BPDQABDMA = 
10, 20, 30, 50 and 70%, where BisGMA/TEGDMA = 50/50. QAB = B12. Specimens 
were tested directly for CS and incubated with S. mutans for 48 h for antibacterial testing 
 
 
Figure 2.8 shows the effect of aging of both unmodified and QAB-modified resin 
composites on CS and S. mutans viability. The mean CS value (MPa) was in the 
decreasing order: (A) Unmodified composite: 1 d > 7 d > 30 d, where there were no 
statistically significant differences between 1 d and 7 d (p > 0.05); (B) QAB-modified 
composite: 1 d > 7 d > 30 d, where all were significantly different from each other (p < 
0.05). The mean S. mutans viability values were statistically the same within 30 days for 
either unmodified or QAB-modified composite (p < 0.05). 
 
Table 2.5 shows the property comparison of the unmodified and modified resin 
composites. These properties include yield strength (YS), compressive modulus (M), CS, 
diametral tensile strength (DTS), flexural strength (FS) and antibacterial activity. 
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Figure 2.8 Effect of aging on CS and S. mutans viability: BPDQABDMA = 30%; 
BisGMA/TEGDMA = 50/50; QAB = B12. The specimens were conditioned in distilled 
water for 1 day, 7 days and 30 days, followed by direct testing for CS and incubating 
with S. mutans for 48 h for antibacterial testing 
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2.4.3  Discussion 
Currently there is a growing interest in preventing or reducing biofilm formation 
in many biomedical areas. In preventive restorative dentistry, secondary caries is a critical 
issue and prevention of secondary caries plays a key role in long-lasting restorations [1-4]. 
Secondary caries is found to be the main reason to the restoration failure of dental 
restoratives [1-4]. Secondary caries that often occurs at the interface between the 
restoration and the cavity preparation is mainly caused by demineralization of tooth 
structure due to invasion of plaque bacteria (acid-producing bacteria) such as S. mutans 
in the presence of fermentable carbohydrates [4]. Therefore, preventing these bacteria 
from invasion to natural tooth is the key to long-lasting dental restorations when the 
microleakage or materials failure occurs at the interface. Quaternary ammonium salts 
(QAS) and their constructed materials represent a new trend of antimicrobial agents in 
biomedical applications [10, 13]. QAS can be incorporated in many ways, including 
mixing with fillers, copolymerizing with other monomers and grafting onto the polymer 
skeletons [10-14]. The advantage of using QAS is that they can kill the microorganisms 
by simple contact. The mechanism of QAS to kill bacteria is believed to disrupt the 
surface membrane of bacteria by changing membrane permeability or surface 
electrostatic balance [11, 18]. In this regard, we purposely synthesized the new QAB-
containing oligomers, incorporated them into the resin composite and evaluated the CS 
and antibacterial activity of the formed composite. 
 
It has been noticed that chain length on QAS has a significant effect on its 
antibacterial activity [11, 14]. Generally speaking, there are four main processes for QAS 
to kill bacteria and they are (1) adsorption onto the negatively charged bacterial cell 
surface; (2) penetrating through the cell wall; (3) binding to the cytoplasmic membrane; 
and (4) disrupting the cytoplasmic membrane [14]. It has also been found that both 
positive charge density and substitute chain length are the key to the biocidal ability, 
because the high positive charge density may enhance the driving force and the long 
substitute chain may strongly interact with the cytoplasmic membranes [14].  From Table 
1, it is apparent that increasing the substitute chain length significantly increased the 
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biocidal activity of the synthesized QAB. The QAB with 16-carbon substitute chain (B16) 
was the highest in MIC whereas the one with 2-carbon chain (B2) was the lowest. In fact, 
the trend for the biocidal activity of the QAB in this study was similar to those described 
elsewhere [11, 14], i.e., the longer the substitute chain, the higher the biocidal activity. 
The same trend was also observed for the resin composites having the QAB-containing 
oligomers with different chain length. As shown in Figure 5, increasing the substitute 
chain length significantly decreased the S. mutans viability. However, the CS value was 
also decreased. The decrease in CS can be attributed to the fact that simply introducing 
the hydrocarbon CH2 unit that does not contain any strong primary bonds such as C=C 
bond or secondary bonds such as dipole-dipole or hydrogen bond could reduce 
mechanical strengths [24]. 
 
 From the results in Figure 6, it is evident that introduction of the QAB 
significantly increased the antibacterial activity (or decreased the S. mutans viability) of 
the resin composite. As compared to the unmodified composite A, the QAB-modified B, 
C and D significantly killed the S. mutans from 31 to 42%. Meanwhile, their CS values 
were also significantly decreased with a reduction of 34-36% for dry composites and 35-
47% for wet composites. The significant decrease in strength for the dry composite can 
be attributed to the introduction of the QAB. The QAB synthesized in this study is 
nothing but a quaternized salt with a long-chain hydrocarbon attached, which does not 
contribute any strength enhancement but rather reduces the amount of C=C instead [24]. 
That is why a significant decrease in CS has been observed. Regarding the dry and wet 
composites, the unmodified composite A behaved very differently from the QAB-
modified B, C and D. No change in CS was found for the composite A after 24 h in water. 
On the other hand, statistically significant differences were found between the dry and 
wet composites for either B, or C or D. This significant decrease in CS can be attributed 
to the hydrophilic nature of the QAB-modified composite. The QAB by nature is a 
quaternary ammonium salt (QAS) bearing both positive and negative charges, which 
absorb water [25]. Since water serves as a plasticizer in the material [26], the QAS-
containing material behaves like a hydrogel more or less [27]. No wonder the QAB-
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modified composites in this study showed decreased CS values after conditioning in 
water. Furthermore, the wet composite B seems to show more decrease in CS than either 
wet C or wet D, which may be attributed to the fact that B contains more QAB in one 
mole due to its lower molecular weight. 
 
The effect of the oligomer loading on CS and antibacterial activity is shown in 
Figure 7. Apparently, the more the QAB-containing oligomer added the lower the CS 
value and the higher the antibacterial activity. With the oligomer increasing from 10 to 
70%, the CS value and S. mutans viability were decreased from 17 to 78% and 16 to 78%, 
respectively. To keep the CS value close to 250 MPa and S. mutans viability close 50%, 
we chose the formulation with 30% of the QAB-containing oligomer to study the aging 
of the modified composite. We tested the CS and S. mutans viability of both unmodified 
and modified composites after conditioning in distilled water for 1 day, 7 days and 30 
days. As shown in Figure 8, there was nearly no change in S. mutans viability for either 
unmodified or modified composites, suggesting that there might be no leachable from the 
modified composite. On the other hand, however, a dramatic decrease in CS (MPa) was 
observed for the modified composite with the results of 241 for 1 day, 183 for 7 days and 
155 for 30 days. In contrast, statistically significant difference was found only between 1 
day (335 MPa) and 30 days (302 MPa) for the unmodified composite. It is known that 
dental resin composites show a certain degree of degradation due to water sorption 
caused by two hydroxyl groups pendent on BisGMA and three -CH2CH2O- units on 
TEGDMA (see structures in Figure 1A) [28]. The absorbed water can hydrolyze the 
silane bond that is used to couple resin with fillers, de-bond the resin-filler interface and 
thus reduce the mechanical strengths with time [28]. That may be why the unmodified 
composite showed a decrease in CS after conditioning in water for 30 days. Regarding 
the QAB-modified composite, the significant decrease in CS should be attributed to the 
hydrophilic nature of the QAB incorporated. As compared to two hydroxyl groups on 
BisGMA, two QAB groups attached to the newly synthesized oligomer would absorb 
water even more aggressively because of the ionic charges they carry [27, 28]. These 
ionic charges can accelerate the interfacial de-bonding. That may be why a dramatic 
                          
 
23 
reduction in CS was observed. Unlike those QAS-modified dental glass-ionomer cements 
[29], the above negative effect to dental resin composites should be cautiously weighed 
while the positive effect of QAS is beneficial in reducing bacteria. In our previous work 
related to glass-ionomer cements, we found that QAS did not degrade the cement during 
the 30-day aging although it reduced the initial strength as well [29]. 
 
Finally, we compared YS, M, CS, DTS, FS and antibacterial activity between 
unmodified and modified composites. The QAB-modified composite was 20 and 55% in 
YS, 14 and 46% in modulus, 34 and 43% in CS, 29 and 46% in DTS and 27 and 37% in 
FS lower than the unmodified composite, respectively, in dry and wet states. On the other 
hand, however, the QAB-modified composite was much higher (37% higher) in 
antibacterial activity than the unmodified composite. 
 
 
2.5  Conclusions 
We have synthesized several novel QAB-containing oligomers and used them for 
formulation of antibacterial resin composites. All the QAB-modified composites showed 
significant antibacterial activity and mechanical strength reduction. It was found that 
increasing chain length and loading significantly enhanced the antibacterial activity but 
also dramatically reduced the CS. The 30-day aging study showed that the incorporation 
of the QAB accelerated the degradation of the composite, suggesting that the QAB may 
not be well suitable for development of antibacterial dental resin composites or at least 
the QAB loading should be well controlled, unlike its use in dental glass-ionomer 
cements. The authors believe that the work in this study is beneficial and valuable to 
those who are interested in studying antibacterial dental resin composites. 
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3.  PREPARATION AND EVALUATION OF A NOVEL ANTIBACTERIAL DENTAL 
RESIN COMPOSITE 
 
 
3.1  Abstract 
 A novel furanone-containing antibacterial resin composite has been prepared 
and evaluated. Compressive strength (CS) and S. mutans viability were used to evaluate 
the mechanical strength and antibacterial activity of the composites. The modified resin 
composites showed a significant antibacterial activity without substantially decreasing 
the mechanical strengths. With 5 to 30% addition of the furanone derivative, the 
composite kept its original CS unchanged but showed a significant antibacterial activity 
with a 16-68% reduction in the S. mutans viability. Further, the antibacterial function of 
the new composite was not affected by human saliva. The aging study indicates that the 
composite may have a long-lasting antibacterial function. Within the limitations of this 
study, it appears that the experimental antibacterial resin composite may potentially be 
developed into a clinically attractive dental restorative due to its high mechanical strength 
and antibacterial function. 
 
 
3.2  Introduction 
Long-lasting restoratives and restoration are clinically attractive because they can 
reduce patents’ pain and expense as well as the number of their visits to dental offices [1-
4]. In dentistry, both restorative materials and oral bacteria are believed to be responsible 
for the restoration failure [2]. Secondary caries is found to be the main reason to the 
restoration failure of dental restoratives including resin composites and glass-ionomer 
cements [1-4]. Secondary caries that often occurs at the interface between the restoration 
and the cavity preparation is primarily caused by demineralization of tooth structure due 
to invasion of plaque bacteria (acid-producing bacteria) such as Streptococcus mutans (S. 
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mutans) in the presence of fermentable carbohydrates [4]. To make long-lasting 
restorations, the materials should be made antibacterial. Although numerous efforts have 
been made on improving antibacterial activities of dental restoratives, most of them have 
been focused on release or slow-release of various incorporated low molecular weight 
antibacterial agents such as antibiotics, zinc ions, silver ions, iodine and chlorhexidine [5-
9]. Yet release or slow-release can lead or has led to a reduction of mechanical properties 
of the restoratives over time, short-term effectiveness, and possible toxicity to 
surrounding tissues if the dose or release is not properly controlled [5-9]. Materials 
containing quaternary ammonium salt (QAS) groups have been studied extensively as an 
important antimicrobial material and used for a variety of applications due to their potent 
antimicrobial activities [10-14]. These materials are found to be capable of killing 
bacteria that are resistant to other types of cationic antibacterials [15]. The examples of 
the QAS-containing materials as antibacterials for dental restoratives include 
incorporation of a methacryloyloxydodecyl pyridinium bromide as an antibacterial 
monomer into resin composites [12], use of methacryloxylethyl cetyl ammonium chloride 
as a component for antibacterial bonding agents [16, 17], and incorporation of quaternary 
ammonium polyethylenimine nanoparticles into resin composites [18, 19]. All these 
studies found that the QAS-containing materials did exhibit significant antibacterial 
activities. However, our recent study found that incorporation of QAS into dental resin 
composites can significantly decrease mechanical strengths due to its strong hydrophilic 
characteristics, if the amount added is beyond a certain limit [20]. In addition, it has been 
reported that human saliva can significantly decrease the antibacterial activity of the 
QAS-containing restoratives, probably due to the electrostatic interactions between QAS 
and proteins in saliva [21-22]. Recently furanone derivatives have been found to have 
strong antitumor [23-24] and antibacterial functions [25]. Therefore, we would like to 
explore them in dental applications. 
 
The objective of this study was to synthesize a new functional furanone derivative, 
incorporate it to dental resin composite, and evaluate its effect on mechanical as well as 
other properties and antibacterial activity of the formed composites. 
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3.3  Experiments 
 
 
3.3.1  Materials 
Bisphenol A glycerolate dimethacrylate (BisGMA), Bisphenol A ethoxylate 
dimethacrylate (BisEMA), urethane dimethacrylate (UDMA), triethylene glycol 
dimethacrylate (TEGDMA), dl-camphoroquinone (CQ), 2-(dimethylamino)ethyl 
methacrylate (DMAEMA), sulfuric acid, toluene, acryloyl chloride (AC), 3,4-
dichloromalealdehydic acid (DA), ethyl acetate and sodium bicarbonate were used as 
received from Sigma-Aldrich Co. (Milwaukee, WI) without further purifications. The 
untreated glass fillers from Herculite XRV (0.7 microns) were used as received from 
Sybron Dental Specialties (Newport Beach, CA). Filtek P-60 resin composite was used as 
received from 3M ESPE (St. Paul, MN). 
 
 
3.3.2   Synthesis of 5-acryloyloxy-3,4-Dichlorocrotonolactone (AD) 
To a solution containing DA (0.5 mol) and toluene, AC (0.52 mol) in toluene was 
added. After the mixture was run at 90-100 oC for 3-4 h, toluene was removed using a 
rotary evaporator. The residue was then washed with sodium bicarbonate and distilled 
water, followed by extracting with ethyl acetate. The formed AD was obtained by 
completely removing ethyl acetate using the rotary evaporator before drying in a vacuum 
oven. The synthesis scheme is shown in Figure 3.1. 
 
 
3.3.3  Characterization 
The chemical structure of the synthesized AD and starting chemicals was 
characterized by Fourier transform-infrared (FT-IR) spectroscopy and nuclear magnetic 
resonance (NMR) spectroscopy. The proton NMR (1HNMR) spectra were obtained on a 
500 MHz Bruker NMR spectrometer (Bruker Avance II, Bruker BioSpin Corporation, 
Billerica, MA) using deuterated dimethyl sulfoxide and chloroform as solvents and FT-IR 
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spectra were obtained on a FT-IR spectrometer (Mattson Research Series FT/IR 1000, 
Madison, WI). 
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Figure 3.1 Schematic diagram for the structures of the oligomers used in the study and 
synthesis of AD from the reaction of DA with AC 
 
 
3.3.4  Sample Preparation 
The experimental resin composites were formulated with a two-component system 
(liquid and powder) [20]. The liquid was formulated with the newly synthesized monomer 
AD, BisGMA, UDMA, BisEMA, CQ (photo-initiator) and DMAEMA (activator). AD was 
mixed with a mixture of BisGMA, UDMA and BisEMA (BisGMA/UDMA/BisEMA = 
1:1:1, by weight) in a ratio of AD/a mixture = 0, 5, 10, 20, 30, 40, 50 and 70% (by weight) 
unless specified. CQ (1.0% by weight) and DMAEMA (2.0%) were added for photo-
initiation. TEGDMA was also used as reference in evaluating viscosities of the formulated 
liquids. The untreated glass Herculite XRV (0.7 microns) powders were used as fillers and 
treated with γ-(trimethoxysilyl)propyl methacrylate, following the published protocol [20]. 
A filler level at 75% (by weight) was used throughout the study unless specified. 
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Specimens were fabricated by thoroughly mixing the liquid with the treated fillers 
at room temperature according to the published protocol [20]. Briefly, the cylindrical 
specimens were prepared in glass tubing with dimensions of 4 mm in diameter by 8 mm 
in length for compressive strength (CS), 4 mm in diameter by 2 mm in length for 
diametral tensile strength (DTS), and 4 mm in diameter by 2 mm in depth for 
antibacterial tests. The rectangular specimens were prepared in a split Teflon mold with 
dimensions of 3 mm in width by 3 mm in thickness by 25 mm in length for flexural 
strength (FS) test.  All the specimens were exposed to blue light (EXAKT 520 Blue Light 
Polymerization Unit, EXAKT Technologies, Inc., Oklahoma City, OK) for 2 min, 
followed by removing from the mold prior to testing. 
 
 
3.3.5  Strength Measurements 
CS, DTS and FS tests were performed on a screw-driven mechanical tester (QTest 
QT/10, MTS Systems Corp., Eden Prairie, MN), with a crosshead speed of 1 mm/min. 
The FS test was performed in three-point bending with a span of 20 mm between 
supports. Six to eight specimens were tested to obtain a mean value for each material or 
formulation in each test. CS was calculated using an equation of CS = P/πr2, where P = 
the load at fracture and r = the radius of the cylinder. DTS was determined from the 
relationship DTS = 2P/πdt, where P = the load at fracture, d = the diameter of the cylinder, 
and t = the thickness of the cylinder. FS was obtained using the expression FS = 3Pl/2bd2, 
where P = the load at fracture, l = the distance between the two supports, b = the breadth 
of the specimen, and d = the depth of the specimen. 
 
 
3.3.6  Other Property Determinations 
The viscosity of the formulated liquid was determined at 23 oC using a cone/plate 
viscometer (RVDV-II+CP, Brookfield Eng. Lab. Inc., MA, USA), as described elsewhere 
[26]. For exotherm measurement, the heat generated from the setting reaction of the resin 
composite was determined with a slightly modified ASTM F-451 procedure [26]. Briefly, 
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the composite paste was placed in a cylindrical Teflon mold with dimensions of 30 mm in 
diameter by 6 mm in height and covered with a Teflon plunger having holes for allowing 
the excessive paste to escape. A digital thermocouple (Fisher Scientific, Springfield, NJ) 
was inserted in the center of the resin composite and used to record the temperature 
change. The peak temperature was defined as the exotherm. The polymerization 
shrinkage was determined using an equation of % Shrinkage = (1 - duncured/dcured) x 100, 
where dcured is the density of cured composite and duncured the density of uncured 
composite [27]. The densities of the uncured and cured composites were determined by 
weighing the uncured composite paste injected from a calibrated syringe which was used 
to determine the volume of the uncured paste and weighing the cured cylindrical 
specimen whose volume was measured in a calibrated buret in the presence of water, 
respectively. The mean values were averaged from three readings. 
 
 
3.3.7  Antibacterial Test 
 The antibacterial test was conducted following the published procedures [20]. 
S. mutans was used to evaluate the antibacterial activity of the studied composites. 
Briefly, colonies of S. mutans were suspended in 5 mL of tryptic soy broth (TSB), 
supplemented with 1% sucrose, to make a suspension with 108 CFU/mL of S. mutans, 
after 24 h incubation. Specimens pretreated with ethanol (10 s) were incubated with S. 
mutans in TSB at 37°C for 48 h under 5% CO2. After equal volumes of the red and the 
green dyes (LIVE/DEAD BacLight bacterial viability kit L7007, Molecular Probes, Inc., 
Eugene, OR, USA) were combined in a microfuge tube and mixed thoroughly for 1 min, 
3 μL of the dye mixture was added to 1 mL of the bacteria suspension, mixed by 
vortexing for 10 s, sonicating for 10 s as well as vortexing for another 10 s, and kept in 
dark for about 15 min, prior to analysis. Then 20 μL of the stained bacterial suspension 
was analyzed using a fluorescent microscope (Nikon Microphot-FXA, Melville, NY, 
USA). Triple replica was used to obtain a mean value for each material. 
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3.3.8  Saliva Effect Test 
 Human saliva, obtained from a healthy volunteer, was centrifuged for 15 min at 
12,000g to remove debris [21]. After the supernatant was filtered with a 0.45-μm sterile 
filter, the filtrate was stored in a -20 oC freezer prior to testing. The sterilized composite 
specimen (refer to Section 2.3.4) was incubated in a small tube containing 1 ml of saliva 
at 37 oC for 2 h [21], followed by placing in 5 ml TSB supplemented with 1% sucrose. 
The rest of the procedures for antibacterial test are described in Section 2.3.4.  
 
 
3.3.9  Aging of the Specimens 
The specimens for both CS and antibacterial activity aging tests were conditioned 
in distilled water at 37 oC for 1 day, 3 days, 7 days and 30 days, followed by direct testing 
for CS (refer to Section 2.3.2 for details) and incubating with S. mutans for 48 h for 
antibacterial testing (refer to Section 2.3.4 for details). 
 
 
3.3.10  Statiscal Analysis 
One-way analysis of variance (ANOVA) with the post hoc Tukey-Kramer 
multiple-range test was used to determine significant differences of mechanical strength 
and antibacterial tests among the materials or formulations in each group. A level of α = 
0.05 was used for statistical significance. 
 
 
3.4  Results and Discussion 
 
 
3.4.1  Characterization 
Figure 3.2 shows the FT-IR spectra for DA, AC and AD. The characteristic peaks 
(cm-1) are listed below: (a) DA: 3362 (O-H stretching on -OH), 1766 (C=O stretching on 
carbonyl group), 1644 (C=C stretching on internal C=C), 1332, 1237 and 949 (C-O-C 
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stretching on pseudo ester), 1451, 1026 and 778 (O-H deformation on pseudo –OH), 
1279, 1118, 889 and 602 (C-O stretching on pseudo C-OH), 746 (C-Cl stretching); (b) 
AC: 1758 (C=O stretching on carbonyl group), 1610 (C=C stretching), 1395 and 1145 
(C-H deformation on –C=C- group), 1284, 1074, 935 and 606 (C-O stretching on 
carbonyl group), 971 and 755 (C-H out of plane vibration on –C=C), 705 (C-Cl 
stretching); (c) AD: 1807 and 1764 (C=O stretching on carbonyl groups of both pseudo 
ester and acrylate), 1639 (C=C stretching on acrylate and internal C=C), 1500 (C-O-C 
deformation on newly formed ester), 1407 and 1137 (C-H deformation on C=C from 
acrylate), 1330 and 1232 (C-O-C stretching on pseudo ester), 1295, 1068, 934 and 608  
(C-O stretching on carbonyl group), 985 (C-H out of plane vibration on –C=C), 889 (C-O 
stretching on newly formed ester), 804 and 670 (C-H vibration on newly formed C=C 
group), 745 (C-Cl stretching on Cl-C=C group). The disappearance of the peak at 3362 
for pseudo hydroxyl group on DA and appearance of the new peaks at 1807, 1764, 1500, 
804 and 670 for both carbonyl and C=C groups on acrylate confirmed the formation of 
AD. 
 
Figure 3.2. FT-IR spectra for DA, AC and AD: (a) DA; (b) AC and (c) AD 
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Figure 3.3 shows the 1HNMR spectra for DA, AC and AD. The chemical shifts 
(ppm) are shown below: (a) DA: 6.25 (-CH) and 3.45 (-OH); (b) AC: 6.21, 6.05 and 5.82 
(H2C=CH-); (c) AD: 7.20 (-CH), 6.55, 6.30 and 6.15 (H2C=CH-). The chemical shift at 
2.50 shown in all the spectra was for solvent d-DMSO. The disappearance of the 
chemical shift at 3.45 (-OH) and all the chemical shifts towards a high field confirmed 
the formation of AD. 
 
 
 
 
Figure 3.3 1HNMR spectra for DA, AC and AD: (a) DA; (b) AC and (c) AD 
 
 
3.4.2  Evaluations 
Table 3.1 shows the effects of different oligomer mixtures and filler loading on 
compressive strengths of the experimental resin composites and on viscosity of the resin 
liquid. For the effect of oligomer mixtures, the mean strength value was in the decreasing 
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order of: YS (MPa):  BisGMA/UDMA > BisGMA/TEGDMA > BisGMA > 
BisGMA/UDMA/BisEMA > BisGMA/BisEMA; M (GPa): BisGMA/TEGDMA > 
BisGMA/UDMA > BisGMA > BisGMA/UDMA/BisEMA > BisGMA/BisEMA; CS 
(MPa): BisGMA/TEGDMA > BisGMA/UDMA/BisEMA > BisGMA/UDMA > 
BisGMA = BisGMA/BisEMA; Viscosity (cp): BisGMA >> BisGMA/UDMA > 
BisGMA/BisEMA > BisGMA/UDMA/BisEMA > BisGMA/TEGDMA. For the effect of 
filler loading, YS: 3.0 > 2.3 > 3.3 > 2.7; M: 3.0 > 3.3 > 2.7 > 2.3; CS: 3.0 > 3.3 > 2.7 > 
2.3. 
 
Table 3.1. Effects of different oligomer mixtures and filler loading on compressive 
strengths of the composites 
 
 YS3 [MPa] M4 [GPa] CS [MPa] Viscosity5 (cp) 
Effect of oligomer1    
 
BisGMA/BisEMA 83.8 (7.7)6 4.53 (0.06) 284.8 (15)e 528 
BisGMA/TEGDMA 133.1 (9.2)a 7.01 (0.16)c 302.6 (18)e 345 
BisGMA/UDMA 139.9 (12)a 6.88 (0.05)c 290.4 (16)e 882 
BisGMA/UDMA/BisEMA 115.4 (6.1)b 5.89 (0.19)d 297.4 (15)e 478 
BisGMA 118.5 (10)b 6.12 (0.07)d 285.6 (9.3)e N/D 
Effect of filler loading2    
 
2.3 108.2 (10)f 5.13 (0.34)g 275.9 (12)i 384 
2.7 103.1 (4.0)f 5.18 (0.21)g 279.9 (12)i 384 
3.0 121. 5 (18) 6.14 (0.53)h 317.0 (13) 384 
3.3 105.5 (6.1)f 6.05 (0.22)h 293.4 (8.4) 384 
 
1The liquid oligomers were mixed in 1:1 and 1:1:1 ratios (by weight) without AD addition; The filler/resin 
ratio = 3.0 or 75% (by weight). 2The resin was composed of AD, BisGMA, UDMA and BisEMA, where 
AD = 30% and BiSGMA/UDMA/BisEMA = 1:1:1; 3YS = CS at yield; 4M = compressive modulus; 
5Viscosity was determined from the liquid resin only and N/D = not determined due to the extremely high 
viscosity of BisGMA; 6Entries are mean values with standard deviations in parentheses and the mean 
values with the same letter in each category were not significantly different (p > 0.05). Specimens were 
directly used for CS testing. 
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Figure 3.4 shows the effect of the AD content on CS and S. mutans viability of 
the experimental composites. For CS (Figure 4a), the mean CS value (MPa) was in the 
decreasing order of 5% > 0% > 10% = 20% = 30% > 40% > 50% > 70%, where there 
were no statistically significant differences among 0%, 5%, 10%, 20% and 30% and 
between 40% and 50% (p > 0.05). The AD addition did not change the CS of the 
composites until reaching 40%. From 40% to 70%, CS decreased 11-27% of its original 
value. The viscosity value was in the decreasing order of 0% > 5% > 10% > 20% > 30% 
> 40% > 50% > 70%.  For the S. mutans viability (Figure 4b), increasing the AD content 
significantly decreased the S. mutans viability. The mean viability values were decreased 
from 82 to 1% with 5 to 70% AD addition and all the values were significantly different 
from each other (p < 0.05). 
 
Figure 3.5 shows the effect of human saliva on the S. mutans viability after 
culturing with the experimental composites. No statistically significant differences in the 
S. mutans viability were found between the experimental composites with and without 
human saliva treatment. 
 
Figure 3.6 shows the effect of the composite aging in water on CS and S. mutans 
viability. For CS (Figure 6a), After 7-day aging in water, all the composites with AD 
addition showed no statistically significant differences in CS from each other (p > 0.05), 
regardless filler loading or aging time. For the S. mutans viability (Figure 6b), no 
statistically significant differences (p > 0.05) were found after 7-day aging at the same 
filler loading, although a slight increase was noticed.  
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Figure 3.4 Effect of the AD content on the viscosity of the resin liquid formulations and 
CS as well as S. mutans viability of the experimental composites: a. Effect on CS and 
viscosity; b. Effect on the S. mutans viability. AD content (%, by weight) = 
AD/(AD/BisGMA/UDMA/BisEMA), where BiSGMA/UDMA/BisEMA = 1:1:1; The 
filler/resin ratio = 3.0 or 75% (by weight).  For CS, specimens were directly used for the 
testing. For the S. mutans viability, specimens were incubated with S. mutans before 
antibacterial testing. 
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Table 3.2 shows a property comparison of the resin composites with and without 
AD addition. The mean values for yield strength (YS), compressive modulus (M), CS, 
diametral tensile strength (DTS) and flexural strength (FS) were in the decreasing order 
of: YS (MPa): 5% > 0% > 10% > 30%, where 0% and 5% were not statistically 
significantly different from each other (p > 0.05); M (GPa): 5% > 0% > 10% > 30%, 
where 0% and 5% were not statistically significantly different from each other (p > 0.05); 
CS (MPa): 0% = 5% = 10% = 30% (p > 0.05); DTS (MPa): 0% > 5% > 10% > 30%, 
where 0%, 5% and 10% were not statistically significantly different from one another; FS 
(MPa): 0% > 5% > 10% > 30%, where 5% and 10% were not statistically significantly 
different from each other (p > 0.05). The mean values for shrinkage, exotherm and S. 
mutans viability were in the decreasing order of: Shrinkage (%): 30% > 10% > 5% > 0%; 
Exotherm (oC): 30% > 10% > 5% > 0%; S. mutans viability (%): 0% > 5% > 10% > 30% 
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Figure 3.5 Effect of human saliva on the S. mutans viability after culturing with the 
composites: The formulations were the same as those described in Figure 4. Specimens 
were soaked in human saliva at 37 oC for 2 h, followed by incubating with S. mutans 
before antibacterial testing 
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Figure 3.6 Effect of aging on CS and S. mutans viability of the experimental composites: 
a. Effect on CS and b. effect on the S. mutans viability. The formulations were the same 
as those described in Figure 4. Specimens were conditioned in distilled water at 37 oC for 
1, 3 and 7 days prior to testing. 
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3.4.3  Discussion 
In preventive restorative dentistry, secondary caries is a critical issue and 
prevention of secondary caries plays a key role in long-lasting restorations [1-4]. So far 
most researchers have been focused on the studies related to release or slow-release of 
various incorporated low molecular weight (MW) antibacterial agents such as antibiotics, 
zinc ions, silver ions, iodine and chlorhexidine (CHX) [5-9]. Yet release or slow-release 
can lead or has led to a reduction of mechanical properties of the restoratives over time, 
short-term effectiveness, and possible toxicity to surrounding tissues if the dose or release 
is not properly controlled [5-9]. Recently research on killing bacteria by touch or simple 
contact has attracted a special attention [11-20]. Materials containing quaternary 
ammonium salt (QAS) groups have been studied extensively as an important 
antimicrobial material and used for a variety of applications due to their potent 
antimicrobial activities [10-19]. These materials are found to be capable of killing 
bacteria that are resistant to other types of cationic antibacterials [15]. However, our 
recent study found that incorporation of QAS into dental resin composites can 
significantly decrease mechanical strengths due to its strong hydrophilic characteristics, if 
the amount added is beyond a certain limit [20]. In addition, it has been reported that 
human saliva can significantly decrease the antibacterial activity of the QAS-containing 
restoratives, probably due to the electrostatic interactions between QAS and proteins in 
saliva [21-22]. Furanone-containing materials are reported to have a broad range of 
biological and physiological properties including antitumor, antibiotic, haemorrhagic and 
insecticidal activity [23-25], although the biological mechanism of these derivatives is 
still under investigation [25]. To explore the application of these compounds in dental 
research, we synthesized a photocurable furanone rerivative and applied it to dental resin 
composites. The following discussion demonstrates how the newly synthesized AD was 
incorporated into a dental composite formulation and its effect on some mechanical, 
physical and antibacterial properties of the formed dental composite. 
 
It is known that commercially available dental resin composites usually contain 
70-80% inorganic fillers and 20-30% of a liquid mixture of BisGMA and TEGDMA or 
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BisGMA with one or two other oligomers including UDMA, BisEMA and TEGDMA [5]. 
In formulating the liquid for resin composites, viscosity is one of the very important 
criteria [5] because it determines what percentage of fillers can be incorporated and what 
properties the formed system might have. During the study, we found that the newly 
synthesized AD has a low viscosity (154 cp), which is just a little bit higher than that for 
TEGDMA (132 cp). To avoid having unexpected low viscosity values and mimic 
commercial resin composite systems, we decided to make a new formulation that 
contains AD while eliminating TEGDMA (commonly used in commercial resin 
composites) [5]. The oligomers including BisGMA, BisEMA and UDMA were used to 
formulate the liquid. While formulating the liquid, we also tested the corresponding CS 
of the formulated composite. As shown in Table 1, the mixture of 
BisGMA/UDMA/BisEMA showed a higher CS and appropriate viscosity value (478 cp). 
With this viscosity, the liquid mixture could be used to formulate with AD without 
changing the viscosity significantly, as compared to the liquid formulation used in 
commercial resin composites (BisGMA/TEGDMA = 345 cp). In fact, the measured 
viscosity values for the liquid formulations composed of AD, BisGMA, BisEMA and 
UDMA (BisGMA/UDMA/BisEMA = 1:1:1) were in the range of 463 to 298 cp 
corresponding to 5-70% AD addition (see Figure 4a). In order to determine how much 
fillers should be incorporated into the resin, we evaluated the effect of the filler content 
on CS and found that the filler/liquid ratio of 3.0 or 75% showed the highest YS, modulus 
and CS values (see Table 1). Thus we chose the mixture of BisGMA/UDMA/BisEMA 
and 75% filler to formulate the antibacterial resin composites. 
 
Next, we evaluated the effect of the AD content on CS and S. mutans viability of 
the experimental composites. From the results in Figure 4a, increasing AD did not 
decrease the CS of the composites until reaching 40%. From 40 to 70%, CS decreased 
11-27% of its original value. For the S. mutans viability (Figure 4b), increasing the AD 
content significantly decreased the S. mutans viability. The mean viability values were 
decreased from 82 to 1% with 5 to 70% AD addition. Apparently with 30% AD addition, 
the resin composite showed the best antibacterial properties without decreasing CS. In 
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other words, the resin composite with 30% AD seemed to be the optimal formulation for 
this new antibacterial dental composite. 
 
Figure 3.5 shows the effect of human saliva on the S. mutans viability after 
culturing with the experimental composites. No statistically significant differences in the 
S. mutans viability were found between the composites with and without human saliva 
treatment. It has been noticed that saliva can significantly reduce the antibacterial activity 
of the QAS or PQAS-containing materials based on the mechanism of contact inhibition 
[21, 22]. The reduction was attributed to the interaction between positive charges on QAS 
or PQAS and amphiphilic protein macromolecules in saliva, thus leading to formation of 
a protein coating which covers the antibacterial sites on QAS or PQAS [21, 22]. Unlike 
QAS or PQASA, AD does not carry any charges. That may be why the AD-modified 
resin composites did not show any reduction in antibacterial activity after treating with 
saliva. 
 
To mimic the resin composites in oral environment, the composites were aged in 
distilled water at 37 oC for 1, 3 and 7 days. The results in Figure 3.6 show that all the 
composites with AD addition showed no statistically significant changes in CS (Figure 
3.5a), regardless filler loading or aging time. No statistically significant changes in the S. 
mutans viability were noticed either. This may indicate that most AD derivatives were 
firmly incorporated into the composites without noticeable leaching.  
 
Finally we measured YS, M, CS, DTS, FS, shrinkage, exotherm and S. mutans 
viability of the resin composites with and without AD addition for all the specimens that 
we have. As shown in Table 2, the composites with 5-30% AD addition were 7-18% in 
YS, 0-15% in modulus, 0-2% in CS, 3-22% in DTS, 13-22% in FS and 16-68% in the S. 
mutans viability lower but 0.13-1.38 times in shrinkage and 0.14-0.56 times in exotherm 
higher than the composite without AD. All these changes can be attributed to the AD 
addition. Unlike those dimethacrylates used in dental resin composites, AD is a 
monoacrylate, which can lead to a decrease in strengths. With increasing AD, shrinkage 
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and exotherm were increased, which can be attributed to the increased quantities of 
carbon-carbon double bonds (C=C) from AD.     
 
 
3.5  Conclusions 
We have developed a novel furanone-containing antibacterial resin composite. 
The modified composite showed a significant antibacterial activity without substantially 
decreasing the mechanical strengths. Human saliva did not affect the antibacterial 
function of the new composite. The aging study indicates that the composite may have a 
long-lasting antibacterial function. Within the limitations of this study, it appears that the 
experimental resin composite may potentially be developed into a clinically attractive 
dental restorative due to its high mechanical strength and antibacterial function. 
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4.  CONCLUSION 
 
 
We have prepared and evaluated both QAB- and furanone-containing antibacterial 
dental resin composite systems. For QAB-modified resin composites, increasing chain 
length and loading significantly enhanced the antibacterial activity but dramatically 
reduced the CS. The long-term aging study showed that the incorporation of the QAB 
accelerated the degradation of the composite, suggesting that the QAB may not be well 
suitable for development of antibacterial dental resin composites or at least the QAB 
loading should be well controlled. For furanone-modified system, with 5 to 30% addition 
of the furanone derivative, the composite kept its original CS unchanged but showed a 
significant antibacterial activity with a 16-68% reduction in the S. mutans viability. The 
human saliva did not affect the antibacterial activity of the furanone-containing 
composites. The long-term aging study indicates that the furanone-modified composites 
may have a long-lasting antibacterial function, due to its unchanged CS and antibacterial 
properties. 
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